Improving Lives Through Nuclear Medicine™

Education

Educational Resources

Jubilant Radiopharma is dedicated to advancing the field of nuclear medicine through education, research, publishing and identification of innovative best practices.

To support this effort, our medical and clinical teams comprised of technologists, clinicians, nuclear pharmacists and other professionals work together with thought leaders in the industry to bring decades of SPECT, PET/CT and regulatory expertise to you and your facility in the form of live and web-based CE presentations, blogs, and newsletters.  We also provide access to nuclear medicine coding and reimbursement assistance. In addition, our subject matter experts are always available to consult on clinical and technical issues related to nuclear agents and provide guidance on regulatory mandates. 

You can rely on Jubilant Radiopharma to help ensure that you have access to the information you need to stay up-to-date on changes in the nuclear medicine industry.

Limited Webinar Series: Better Results Start with Better Images

We are pleased to welcome Dr. Douglas Van Nostrand,MD, FACP, FACNM as the guest speaker for our Webinar on Enhanced Techniques to Increase the Utility of Radioiodine Imaging in Patients with Differentiated Thyroid Cancer (DTC).  

Dr. Van Nostrand has been actively involved in thyroid cancer diagnosis and treatment for over 40 years.   He has won numerous awards, most recently, the Saul Hertz 2020 Life Time Achievement Award in I-131 diagnosis and therapy of DTC and has published more than 300+ abstracts, articles, chapters, and 10 books.

In this session, Dr. Van Nostrand explains how successful patient treatment and outcomes are directly related to the interpretation of images, which are only as good as the quality of the images obtained. This course will provide improved imaging techniques to increase the quality of thyroid imaging for better patient outcomes. 

CLICK HERE TO REGISTER

Tuesday, March 16   |   12:00pm - 1:00pm EST
Thursday March 18  |   2:00pm - 3:00pm EST
Tuesday, March 24   |    4:00pm - 5:00pm EST

 

Jubilant Radiopharma Resources

For an overview of our Reimbursement Services click here

For educational resources from our Radiopharmaceuticals Division, click here.

For educational resources from our Radiopharmacies Division,     click here.

Online Continuing Education

In support of our mission of Improving Lives Through Nuclear Medicine, Jubilant Radiopharma proudly sponsors The Society of Nuclear Medicine and Molecular Imaging’s Value Initiative.

As contributing members of the Value Initiative’s Leadership Circle, we promote a wide-range of educational opportunities that help nuclear medicine physicians and technologists develop practice competency and expertise in state-of-the-art nuclear medicine, molecular imaging and radionuclide therapy, so they can achieve the high-quality desired health outcomes nuclear medicine can provide.

To start earning your credits today, please click on one of the courses below or click here to view the full catalog of live and on demand courses.

Category

SNMMI Course Title

Cardiology

Considerations for Implementing a Successful Cardiac PET Program

Myocardial Perfusion Imaging

Pharmacologic Stress Testing with Myocardial Perfusion Imaging

Neuroendocrine Tumor

New Approaches for Diagnosis and Treatment of NETs

Using 68GA-DOTATATE in the Management of Neuroendocrine Tumor Patients

Prostate

SNMMI/ACNM Joint Webinar: Ga68 PSMA Imaging - Pearls or Pitfalls?

Changing the Standard of Care in Prostate Cancer with Advances in Nuclear Medicine, PET and Theranostics

Quality & USP

USP General Chapter <825> Impact on Nuclear Medicine Technology Practice - JNMT (June 2020)

Quarterly Technologist Webinar Series: Are You Ready for USP <825>

Radionuclide Therapy

I-131 MIBG Therapy for Neuroblastoma 

Peptide Receptor Radiotherapy for Neuroendocrine Tumors

Renal

Survey on the Use of Nuclear Renal Imaging in the United States

Thyroid

SNMMI Procedure Standard for Scintigraphy for Differentiated Thyroid Cancer

 

 

We use cookies to recognize your repeat visits and preferences, as well as to measure the effectiveness
of campaigns and analyze traffic. If you continue to use this site we will assume your acceptance.